To study Smad4 reactivation in metastatic tumors, we turned to transplantation assays using cell lines derived from primary GEMM tumors that were capable of metastasis, as this approach afforded longer experimental time before tumor burden necessitated mouse euthanasia. The gene discussed is SMAD4; the disease is neoplasm.